New Therapeutics Options in Pancreatic Ductal Adenocarcinoma Pipeline as 40+ Key Companies are Working on Drug Profiles | DelveInsight
14 sept. 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- New Therapeutics Options in Pancreatic Ductal Adenocarcinoma Pipeline as 40+ Key Companies are Working on Drug Profiles | DelveInsight ...